Cancer Research Cell Death Mechanisms and Cancer Therapy  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pajonk, F.
Right arrow Articles by McBride, W. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pajonk, F.
Right arrow Articles by McBride, W. H.
[Cancer Research 65, 4836-4843, June 1, 2005]
© 2005 American Association for Cancer Research


Experimental Therapeutics, Molecular Targets, and Chemical Biology

Hyperthermia-Induced Proteasome Inhibition and Loss of Androgen Receptor Expression in Human Prostate Cancer Cells

Frank Pajonk1, Arndt van Ophoven2 and William H. McBride1

1 Department of Radiation Oncology, Experimental Division, David Geffen School of Medicine at UCLA, Los Angeles, California and 2 Department of Urology, University Hospital of Münster, Westfälische, Wilhelmsuniversität Münster, Münster, Germany

Requests for reprints: Frank Pajonk, Department of Radiation Oncology, Experimental Division, David Geffen School of Medicine at University of California at Los Angeles, Box 951714, Los Angeles, CA 90095-1714. Phone: 310-825-8589; E-mail: fpajonk{at}mac.com.

Prostate cancer is the second leading cause of death in men in western countries and is usually treated by surgery and/or radiotherapy. More recently, hyperthermia has been introduced into clinical trials investigating a possible effect in the first-line treatment of prostate cancer. However, the molecular mechanisms of hyperthermia are not completely understood. In this study, we investigated the effects of hyperthermia on proteasome function and its significance for signal transduction, cell death and androgen receptor (AR) expression in PC-3, LnCaP, and DU-145 human and TRAMP-C2 murine prostate cancer cells. Hyperthermia caused apoptosis and radiosensitization and decreased 26S proteasome activity in all three human cell lines to about 40% of untreated control cells. 20S proteasome activity was not affected by heat. Heat treatment inhibited constitutive and radiation-induced activation of nuclear factor {kappa}B caused by stabilization of I{kappa}B. Although stabilization of AR by proteasome inhibitors has been reported previously, AR protein levels in LnCaP cells decreased dramatically after heat. Our data suggest that inhibition of proteasome function and dependent signal transduction pathways might be a major molecular mechanisms of heat-induced apoptosis and radiosensitization. Hyperthermia abrogates AR expression in androgen-dependent cells and might thus promote malignant progression of prostate cancer.




This article has been cited by other articles:


Home page
JNCI J Natl Cancer InstHome page
E. Vlashi, K. Kim, C. Lagadec, L. D. Donna, J. T. McDonald, M. Eghbali, J. W. Sayre, E. Stefani, W. McBride, and F. Pajonk
In Vivo Imaging, Tracking, and Targeting of Cancer Stem Cells
J Natl Cancer Inst, March 4, 2009; 101(5): 350 - 359.
[Abstract] [Full Text] [PDF]


Home page
In VivoHome page
G. BARONZIO, A. GRAMAGLIA, and G. FIORENTINI
Current Role and Future Perspectives of Hyperthermia for Prostate Cancer Treatment
In Vivo, January 1, 2009; 23(1): 143 - 146.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Chen, H. Cai, J.-L. Yang, C.-L. Lu, T. Liu, W. Yang, J. Guo, X.-Q. Hu, C.-H. Fan, Z.-Y. Hu, et al.
Effect of Heat Stress on Expression of Junction-Associated Molecules and Upstream Factors Androgen Receptor and Wilms' Tumor 1 in Monkey Sertoli Cells
Endocrinology, October 1, 2008; 149(10): 4871 - 4882.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
L. C. Tu, X. Yan, L. Hood, and B. Lin
Proteomics Analysis of the Interactome of N-myc Downstream Regulated Gene 1 and Its Interactions with the Androgen Response Program in Prostate Cancer Cells
Mol. Cell. Proteomics, April 1, 2007; 6(4): 575 - 588.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. Yang, G. Shi, and Q. P. Dou
The Tumor Proteasome Is a Primary Target for the Natural Anticancer Compound Withaferin A Isolated from "Indian Winter Cherry"
Mol. Pharmacol., February 1, 2007; 71(2): 426 - 437.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.